Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
John Cockerill India secured a ₹1,250-1,300 crore contract from JSW Vijayanagar Metallics to supply and commission CRNO steel processing lines over 36 months from May 2026.
Sensex and Nifty 50 faced weak opening cues amid US-Iran tensions and rising crude, with analysts flagging tight support zones and near-term resistance hurdles.
Indian equities fell over 1% as Iran-US tensions lifted oil prices, the rupee hit 94.85 per dollar, FIIs sold heavily, and IT shares tumbled amid global tech weakness.
Vodafone Idea shares extended their recent rally to a fresh 52-week high, supported by rating actions, a Citi target hike, and improving operating signals like subscriber additions.
Borosil Renewables flagged higher gas-cost risks linked to the West Asia war, while moving to exit its German unit and revive India capacity expansion after anti-dumping duties.
Shilpa Medicare shares fell 2.52% to Rs 361.10 after the API and formulations maker disclosed an acquisition plan and a 40% stake purchase, with share acquisition cost cited at Rs 4.05 crore.
Concord Biotech shares rose after USFDA approved its ANDA for Mycophenolate Mofetil oral suspension, adding to its transplant immunosuppressant portfolio and investor focus.
Concord Biotech received USFDA approval for an ANDA for Mycophenolate Mofetil oral suspension, keeping the stock in focus as brokerages flag FY27 growth visibility and risks.
Marathon Nextgen Realty posted a record FY26 PAT of ₹206 crore, turned net debt-free after a ₹900 crore QIP, and expanded its project pipeline amid inventory and NCLT timelines.
Alkem Laboratories shares are in focus after promoter-linked entities sold 1.49% via a Rs 930 crore block deal at Rs 5,200, with mutual funds and global banks buying.
Concord Biotech received USFDA approval for its ANDA for Mycophenolate Mofetil oral suspension, with the stock up 10% and Jefferies maintaining a Hold rating.
Bliss GVS Pharma extended a sharp multi-session rally after Anupam Rasayan announced a 43.3% acquisition and open offer, with profits up 128.96% year-on-year.
NHPC shares fell as the Government of India launched a 3% OFS with a 3% green shoe at a ₹71 floor price, about 8% below the prior close.
Rajputana Stainless reported a 58% YoY jump in Q4FY26 profit to ₹13.1 crore, aided by a 191 bps margin expansion and FY26 revenue crossing ₹1,000 crore.
Foreign investors have accelerated secondary-market selling in 2026 to over ₹400 crore per trading hour, with year-to-date outflows already exceeding the full-year 2025 total.
ICRA reported FY26 consolidated revenue of ₹599.5 crore and PBT of ₹257.4 crore, while recommending a ₹105 final dividend as Research and Analytics outpaced Ratings.